Anqing Changfan Medical Instrument Co., Ltd. Supplier Evaluation

Supplier Evaluation Report: Anqing Changfan Medical Instrument Co., Ltd.

Executive Summary

Anqing Changfan Medical Instrument Co., Ltd. is a China-based supplier located in Anhui, offering orthopedic and surgical repair-related products such as meniscal repair systems, shoulder anchor systems, and orthopedic surgery instruments. Based on the provided data, the company has a factory area of over 7,300㎡ and more than 40 staff, indicating a small-to-medium manufacturing setup with basic production capacity. The supplier has Gold Supplier status for 3 years, supports Trade Assurance, and is marked as a verified supplier, which provides a reasonable level of platform credibility. Its commercial performance is relatively strong, with 300+ orders and CN¥2.5M+ transaction value in the past six months, supported by a 4.7 store rating and 70+ reviews. However, available data does not confirm finished product inspection, medical regulatory certifications, or full customization capability. This supplier may be suitable for buyers seeking low-MOQ orthopedic repair products, but quality documentation and compliance verification should be conducted before formal procurement.

Detailed Analysis

1. Company Strength

Basis

• Factory location: Anhui, China
• Factory area: 7,300+㎡
• Employees: 40+ staff
• Verified supplier / factory audit status: True
• Product scope includes orthopedic repair systems and surgical instruments based on listed products.

Elaboration

The supplier has a physical manufacturing base of over 7,300㎡, which suggests a meaningful operational footprint rather than a purely trading-oriented setup. The employee count of 40+ indicates a relatively lean organization, more consistent with a small-to-medium-sized manufacturer rather than a large-scale industrial supplier. The verified supplier status adds credibility to the existence and basic operational capacity of the company.

The listed products are specialized medical and orthopedic-related instruments, but the provided data does not include detailed production line capacity, annual output, cleanroom conditions, equipment lists, or medical manufacturing certifications. Therefore, while the company appears to have basic manufacturing strength, its production scalability cannot be fully verified from the available information.

Scoring Rationale

The company has a reasonable factory area and verified supplier status, supporting a score above the basic capability range. However, the staff size is modest, and there is insufficient data on production capacity, equipment level, or formal factory certifications beyond the verified supplier indicator. This prevents classification as a large-scale stable supply chain.

Final Score

15 / 20

2. Platform & Compliance Credibility

Basis

• Gold Supplier: True
• Gold Supplier duration: 3 years
• Trade Assurance: True
• Verified supplier status: True
• Platform/industry labels:
• Response time ≤2h
• ODM service available
• On-time delivery 88.2%
• Warranty available

Elaboration

The supplier has a relatively complete platform credibility profile, including Gold Supplier status, Trade Assurance support, and verified supplier status. A 3-year Gold Supplier history indicates some platform continuity, though it is not yet long-term compared with suppliers that have maintained verified platform status for many years.

Trade Assurance provides a transactional safeguard for buyers, and the verified supplier status improves confidence in the supplier’s basic legitimacy. However, the data does not provide details of internationally recognized medical device certifications, product compliance certificates, factory management system certifications, or regulatory approvals. Since the products are medical and orthopedic-related, the absence of such compliance documentation is a notable limitation.

Scoring Rationale

The supplier has core platform credibility elements: Gold Supplier, Trade Assurance, and verified supplier status. However, the Gold Supplier duration is moderate at 3 years, and there is insufficient data on formal industry certifications or product compliance documentation. Therefore, the supplier fits the range of having core platform credentials but incomplete compliance transparency.

Final Score

16 / 20

3. Business Performance

Basis

• Orders in the past 6 months: 300+
• Transaction value in the past 6 months: CN¥2.5M+
• Store rating: 4.7
• Number of reviews: 70+

Elaboration

The supplier shows relatively solid recent commercial activity, with more than 300 orders and over CN¥2.5M in transaction value in the past six months. This indicates active market demand and a certain level of buyer acceptance. For specialized orthopedic repair and surgical instrument products, this order volume appears commercially meaningful based strictly on the provided figures.

The store rating of 4.7 is positive, although not perfect. The 70+ reviews provide some customer feedback base, but the review volume is moderate rather than extensive. The combination of transaction volume, order count, rating, and reviews suggests the supplier has achieved stable business performance on the platform, though not enough evidence is available to classify it as a top-tier high-volume supplier with extensive customer validation.

Scoring Rationale

The supplier demonstrates strong recent transaction activity and a good store rating. The order count and transaction amount support a high score. However, the review count is only moderate, and the 4.7 rating, while good, does not indicate exceptional customer satisfaction. A score slightly below the top range is appropriate.

Final Score

17 / 20

4. Service Capability

Basis

• Communication response time: ≤2h
• Platform label: ODM service available
• Full Customization: Insufficient Data

Elaboration

The supplier has a stated response time of within 2 hours, which indicates acceptable communication efficiency for platform-based sourcing. The ODM service availability suggests that the supplier may support some level of product development or adaptation based on buyer requirements.

However, the provided data does not confirm Full Customization capability. Since the scoring standard specifically considers Full Customization, the absence of this information limits the service capability assessment. The response time is also not within ≤1 hour, which would be required for the highest service capability range.

Scoring Rationale

The supplier demonstrates normal-to-good responsiveness and some customization-related service through ODM availability. However, there is no confirmed Full Customization capability, and response time is ≤2h rather than ≤1h. Therefore, the supplier fits the middle service capability range.

Final Score

7 / 10

5. Delivery Performance

Basis

• On-time delivery rate: 88.2%

Elaboration

The supplier’s on-time delivery rate is 88.2%, which falls within the 80%–89% range. This indicates generally acceptable delivery reliability, but it does not reach the 90%+ benchmark typically associated with strong delivery performance.

For medical and orthopedic-related products, delivery reliability can be important for distributors, clinics, or procurement teams managing inventory continuity. An 88.2% on-time rate suggests that buyers should monitor lead times carefully, especially for repeat or time-sensitive orders.

Scoring Rationale

According to the scoring standard, an on-time delivery rate between 80% and 89% corresponds to 7–8 points. At 88.2%, the supplier is near the upper end of this range but still below the 90% threshold. Therefore, an upper-middle score is justified.

Final Score

8 / 10

6. Quality & Customer Feedback

Basis

• Store rating: 4.7
• Number of reviews: 70+
• Verified supplier / factory audit status: True
• Finished Product Inspection: Insufficient Data
• Medical product certifications or regulatory approvals: Insufficient Data

Elaboration

The supplier has a 4.7 store rating and more than 70 reviews, indicating generally positive customer feedback. The verified supplier status also provides some level of assurance regarding the company’s legitimacy and basic factory verification.

However, the provided data does not confirm Finished Product Inspection, which is a key quality assurance factor in the scoring framework. Additionally, since the products listed are orthopedic and surgical-related, the absence of provided medical device certifications or regulatory compliance documentation is an important data gap. This does not mean such certifications do not exist, but they cannot be credited in this evaluation without evidence.

Scoring Rationale

The supplier has a good rating and moderate review base, along with verified supplier status. These factors support a quality score in the good range. However, the lack of confirmed Finished Product Inspection and insufficient data on product compliance or medical quality systems prevent a higher score.

Final Score

15 / 20

Total Score

Procurement Recommendation

Recommendation: Conditional Cooperation Recommended

Anqing Changfan Medical Instrument Co., Ltd. is a viable supplier candidate for buyers seeking orthopedic repair systems, shoulder anchor systems, meniscal repair systems, and related surgical instruments with low MOQ requirements. The supplier shows solid platform credibility, active recent transaction performance, acceptable response time, and generally positive customer feedback.

Suitable customer types: - Buyers seeking small-batch or trial orders due to MOQ of 1 set on listed products
- Distributors or sourcing teams evaluating orthopedic repair-related product suppliers
- Buyers who prioritize Trade Assurance and verified supplier status

Main risk points: - Finished Product Inspection: Insufficient Data
- Medical certifications or regulatory approvals: Insufficient Data
- Full Customization capability: Insufficient Data
- On-time delivery rate is 88.2%, below the 90% high-performance threshold
- Employee count of 40+ suggests limited scale compared with larger manufacturers

Growth potential: The supplier has strong recent transaction activity, with 300+ orders and CN¥2.5M+ transaction value in the past six months. If the company can provide stronger documentation for product inspection, medical compliance, and quality management, its procurement suitability would improve significantly. For now, buyers should proceed with sample validation, document review, and quality inspection before placing larger or repeated orders.